おすすめの製品
形状
solid
色
white
溶解性
H2O: 0.15 mg/mL
DMSO: 0.2 mg/mL
0.1 M NaOH: >10 mg/mL
SMILES記法
N[C@@H](Cc1cccc(c1)-c2ccccc2CP(O)(O)=O)C(O)=O
InChI
1S/C16H18NO5P/c17-15(16(18)19)9-11-4-3-6-12(8-11)14-7-2-1-5-13(14)10-23(20,21)22/h1-8,15H,9-10,17H2,(H,18,19)(H2,20,21,22)/t15-/m0/s1
InChI Key
NCEGJIHRQBRVJQ-HNNXBMFYSA-N
遺伝子情報
human ... GRIN1(2902)
生物化学的/生理学的作用
Selective strychnine-sensitive glycine receptor antagonist.
法的情報
Made and sold under license from Nippon Chemiphar.
保管分類コード
11 - Combustible Solids
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
個人用保護具 (PPE)
Eyeshields, Gloves, type N95 (US)
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Soft matter, 14(17), 3372-3377 (2018-04-06)
An external electric AC field with a field strength ranging from 10 V mm-1 to 30 V mm-1 and a frequency ranging from 0.1 kHz to 1 MHz was applied to suspensions of gold nanoparticles (Au NPs) to control their
British journal of pharmacology, 113(1), 165-170 (1994-09-01)
1. 3-[2'-Phosphonomethyl[1,1'-biphenyl]-3-yl]alanine (PMBA) is a novel glycine antagonist at strychnine-sensitive receptors. The chemical structure of PMBA, possessing both a glycine moiety and a phosphono group, is quite different from that of strychnine. 2. In the spinal motoneurone of newborn rats
Journal of biomedical materials research. Part A, 108(10), 2090-2099 (2020-04-24)
Current chemotherapy methods have limited effectiveness in eliminating bone metastasis, which leads to a poor prognosis associated with severe bone disorders. To provide regional chemotherapy for this metastatic tumor, a bone-targeting drug carrier was produced by introducing the osteotropic bisphosphonate
Journal of colloid and interface science, 566, 202-210 (2020-02-02)
Assembly of plasmonic nanoparticle clusters having hotspots in a specific space is an effective way to efficiently utilize their plasmonic properties. In the assembly, however, bulk-like aggregates of the nanoparticles are readily formed by strong van der Waals forces, inducing
IET nanobiotechnology, 13(8), 808-815 (2019-10-19)
Breast cancer is the second cause of death in the world. Ionising radiation is a potent mutagen that can cause DNA damage, chromosomes breakage, and cell death. In the present study, radiotherapy and nanoparticle-antibodies (ABs) have been combined to enhance
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)